Burden of non-cancer comorbidities and mortality in chronic pancreatitis: a retrospective cohort study

Shauntelle Quammie1,2, Adil Rashid1,3, Rahul Munyal4

  • 1NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK.

Insights

Patients with chronic pancreatitis (CP) face significantly higher risks of serious comorbidities like heart failure and diabetes. This progressive disease also leads to substantially increased mortality rates compared to the general population.

Area of Science:

  • Gastroenterology and Hepatology
  • Epidemiology
  • Internal Medicine

Background:

  • Chronic pancreatitis (CP) is a severe fibro-inflammatory condition.
  • CP is linked to increased comorbidities and mortality.
  • Understanding the natural history of CP is crucial for patient management.

Purpose of the Study:

  • To characterize the natural history of chronic pancreatitis.
  • To assess comorbidity prevalence in a CP cohort.
  • To evaluate mortality rates in patients with CP.

Main Methods:

  • Retrospective cohort study at Nottingham University Hospitals NHS Trust.
  • Included patients diagnosed with CP between 2006 and 2014.
  • Follow-up until May 2023, comparing comorbidity and mortality with national data.

Main Results:

  • Patients with CP showed significantly elevated standardized prevalence ratios (SPRs) for heart failure, diabetes mellitus, ischemic heart disease, atrial fibrillation, and cerebrovascular disease.
  • Cumulative incidence at 20 years for diabetes mellitus, chronic liver disease, and chronic kidney disease was 11-12%.
  • A high mortality rate was observed, with a standardized mortality ratio (SMR) of 2.3 compared to the general population. Leading causes of death included malignancy, infections, and cardiovascular disease.

Conclusions:

  • Chronic pancreatitis is associated with a significantly increased risk of multiple comorbidities.
  • Patients with CP experience elevated mortality rates compared to the general population.
  • Enhanced surveillance and early intervention strategies are recommended to manage CP-associated conditions.
Abstract

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...